Changes of Body Weight and Body Composition in Obese Patients with Prader-Willi Syndrome at 3 and 6 Years of Follow-Up: A Retrospective Cohort Study.

(One woman was taking a statin at baseline but not at 3 and 6 years, and another woman was under statin treatment at the 3- and 6-year follow-up visits.) Except for glucose, which showed an increasing trend possibly reflecting an underlying propension of PWS, the mean values of the remaining laboratory markers showed a favorable trend, i.e., increase of HDL cholesterol, decrease in triglycerides, and decrease in systolic and diastolic blood pressure.

also in 1,335 other papers